Brain cytokines as neuromodulators in cardiovascular control

Clinical and Experimental Pharmacology and Physiology

Volumn 37, Issue 2, 2010, Pages

  Shi, Peng ^a   Raizada, Mohan K ^a   Sumners, Colin ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Angiotensin; Anti inflammatory cytokine; Brain; Hypertension; Pro inflammatory cytokine

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; AMPA RECEPTOR; ANGIOTENSIN II; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYTOKINE; CYTOKINE RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1ALPHA; MIGRATION INHIBITION FACTOR; MINOCYCLINE; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN E2; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; TUMOR NECROSIS FACTOR ALPHA;

BLOOD BRAIN BARRIER; CARDIOVASCULAR FUNCTION; CELL ACTIVATION; DRUG INHIBITION; HEART FAILURE; HEART VENTRICLE HYPERTROPHY; HYPERTENSION; MICROGLIA; NERVE CELL; NEUROMODULATION; NONHUMAN; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; REVIEW;

ANIMALS; BLOOD PRESSURE; BRAIN; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; CYTOKINES; HYPERTENSION; MICE; NITRIC OXIDE; RATS; RECEPTORS, CYTOKINE; SYMPATHETIC NERVOUS SYSTEM;

EID: 75649130755     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2009.05234.x     Document Type: Review

References (55)

1. Chae CU, Lee RT, Rifai N, Ridker PM. Blood pressure and inflammation in apparently healthy men. Hypertension 2001 38 : 399 403.
2. Schillaci G, Pirro M, Gemelli F et al. Increased C-reactive protein concentrations in never-treated hypertension: The role of systolic and pulse pressures. J. Hypertens. 2003 21 : 1841 1846.
3. Stumpf C, John S, Jukic J et al. Enhanced levels of platelet P-selectin and circulating cytokines in young patients with mild arterial hypertension. J. Hypertens. 2005 23 : 995 1000.
4. Engstrom G, Lind P, Hedblad B, Stavenow L, Janzon L, Lindgarde F. Long-term effects of inflammation-sensitive plasma proteins and systolic blood pressure on incidence of stroke. Stroke 2002 33 : 2744 2749. (Pubitemid 35462837)
5. Grundy SM. Inflammation, hypertension, and the metabolic syndrome. JAMA 2003 290 : 3000 3002.
6. Nomoto T, Okada T, Shimazaki K et al. Systemic delivery of IL-10 by an AAV vector prevents vascular remodeling and end-organ damage in stroke-prone spontaneously hypertensive rat. Gene Ther. 2009 16 : 383 391.
7. Nonaka-Sarukawa M, Okada T, Ito T et al. Adeno-associated virus vector-mediated systemic interleukin-10 expression ameliorates hypertensive organ damage in Dahl salt-sensitive rats. J. Gene Med. 2008 10 : 368 374.
8. Rajappa M, Sen SK, Sharma A. Role of pro-/anti-inflammatory cytokines and their correlation with established risk factors in south indians with coronary artery disease. Angiology. Epub 15 September 2008 doi :.
9. Sriramula S, Haque M, Majid DS, Francis J. Involvement of tumor necrosis factor-alpha in angiotensin II-mediated effects on salt appetite, hypertension, and cardiac hypertrophy. Hypertension 2008 51 : 1345 1351.
10. Sun C, Li H, Leng L, Raizada MK, Bucala R, Sumners C. Macrophage migration inhibitory factor: An intracellular inhibitor of angiotensin II-induced increases in neuronal activity. J. Neurosci. 2004 24 : 9944 9952.
11. Paton JF, Waki H. Is neurogenic hypertension related to vascular inflammation of the brainstem? Neurosci. Biobehav. Rev. 2009 33 : 89 94.
12. Yu Y, Zhang ZH, Wei SG et al. Central gene transfer of interleukin-10 reduces hypothalamic inflammation and evidence of heart failure in rats after myocardial infarction. Circ. Res. 2007 101 : 304.
13. Cunha JM, Cunha FQ, Poole S, Ferreira SH. Cytokine-mediated inflammatory hyperalgesia limited by interleukin-1 receptor antagonist. Br. J. Pharmacol. 2000 130 : 1418 1424.
14. John CD, Buckingham JC. Cytokines: Regulation of the hypothalamo- pituitary-adrenocortical axis. Curr. OpPharmacol. 2003 3 : 78 84.
15. Quan N, Herkenham M. Connecting cytokines and brain: A review of current issues. Histol. Histopathol. 2002 17 : 273 288.
16. Agnati LF, Zoli M, Stromberg I, Fuxe K. Intercellular communication in the brain: Wiring versus volume transmission. Neuroscience 1995 69 : 711 726.
17. Bucinskaite V, Kurosawa M, Lundeberg T. Effect of interleukin-1beta on subdiaphragmatic vagal efferents in the rat. Auton. Neurosci. 2000 85 : 93 7.
18. Raison CL, Capuron L, Miller AH. Cytokines sing the blues. Inflammation and the pathogenesis of depression. Trends Immunol. 2006 27 : 24 31.
19. Waki H, Gouraud SS, Maeda M, Paton JF. Gene expression profiles of major cytokines in the nucleus tractus solitarii of the spontaneously hypertensive rat. Auton. Neurosci. 2008 142 : 40 4.
20. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 2001 19 : 683 765.
21. Utsuyama M, Hirokawa K. Differential expression of various cytokine receptors in the brain after stimulation with LPS in young and old mice. Exp. Gerontol. 2002 37 : 411 420.
22. Fubini B, Hubbard A. Reactive oxygen species (ROS) and reactive nitrogen species (RNS) generation by silica in inflammation and fibrosis. Free Radic. Biol. Med. 2003 34 : 1507 1516.
23. Schweighofer B, Schultes J, Pomyje J, Hofer E. Signals and genes induced by angiogenic growth factors in comparison to inflammatory cytokines in endothelial cells. ClHemorheol. Microcirc. 2007 37 : 57 62.
24. Zernecke A, Bernhagen J, Weber C. Macrophage migration inhibitory factor in cardiovascular disease. Circulation 2008 117 : 1594 1602.
25. Sun C, Li H, Gao Y et al. Lack of macrophage migration inhibitory factor regulation is linked to the increased chronotropic action of angiotensin II in SHR neurons. Hypertension 2007 49 : 528 534.
26. Rijkers K, Majoie HJ, Hoogland G, Kenis G, De Baets M, Vles JS. The role of interleukin-1 in seizures and epilepsy: A critical review. Exp. Neurol. 2009 216 : 258 271.
27. Liu T, Young PR, McDonnell PC, White RF, Barone FC, Feuerstein GZ. Cytokine-induced neutrophil chemoattractant mRNA expressed in cerebral ischemia. Neurosci. Lett. 1993 164 : 125 128.
28. 2+-permeable alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate (AMPA)/kainate (Ca-A/K) channels in a subset of hippocampal pyramidal neurons. Exp. Neurol. 2005 193 : 384 393.
29. Ishinaga H, Jono H, Lim JH et al. Synergistic induction of nuclear factor-kappaB by transforming growth factor-beta and tumour necrosis factor-alpha is mediated by protein kinase A-dependent RelA acetylation. Biochem. J. 2009 417 : 583 591.
30. Viviani B, Bartesaghi S, Gardoni F et al. Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J. Neurosci. 2003 23 : 8692 8700.
31. Kang YM, Ma Y, Elks C, Zheng JP, Yang ZM, Francis J. Cross-talk between cytokines and renin-angiotensin in hypothalamic paraventricular nucleus in heart failure: Role of nuclear factor-kappaB. Cardiovasc. Res. 2008 79 : 671 678.
32. Kang YM, Ma Y, Zheng JP et al. Brain nuclear factor-kappa B activation contributes to neurohumoral excitation in angiotensin II-induced hypertension. Cardiovasc. Res. 2009 82 : 503 512.
33. Peterson JR, Sharma RV, Davisson RL. Reactive oxygen species in the neuropathogenesis of hypertension. Curr. Hypertens. Rep. 2006 8 : 232 241.
34. Mir M, Tolosa L, Asensio VJ, Llado J, Olmos G. Complementary roles of tumor necrosis factor alpha and interferon gamma in inducible microglial nitric oxide generation. J. Neuroimmunol. 2008 204 : 101 109.
35. Li DP, Chen SR, Finnegan TF, Pan HL. Signalling pathway of nitric oxide in synaptic GABA release in the rat paraventricular nucleus. J. Physiol. 2004 554 : 100 110.
36. Kannan H, Tanaka Y, Kunitake T, Ueta Y, Hayashida Y, Yamashita H. Activation of sympathetic outflow by recombinant human interleukin-1beta in conscious rats. Am. J. Physiol. 1996 270 : R479 85.
37. Kimura T, Yamamoto T, Ota K et al. Central effects of interleukin-1 on blood pressure, thermogenesis, and the release of vasopressin, ACTH, and atrial natriuretic peptide. Ann. N. Y. Acad. Sci. 1993 689 : 330 345.
38. 1 receptors inhibits pressor action of centrally administered interleukin-1beta in Sprague Dawley rats. Neuropeptides 2005 39 : 581 585.
39. Lu Y, Chen J, Yin X, Zhao H. Angiotensin II receptor 1 involved in the central pressor response induced by interleukin-1beta in the paraventricular nucleus. Neurol. Res. 2008 32 : 420 424.
40. Murray PJ. The primary mechanism of the IL-10-regulated antiinflammatory response is to selectively inhibit transcription. Proc. Natl Acad. Sci. USA 2005 102 : 8686 8691.
41. Thiele M, Bernhagen J. Link between macrophage migration inhibitory factor and cellular redox regulation. Antioxid. Redox Signal. 2005 7 : 1234 1248. (Pubitemid 41232520)
42. Li H, Gao Y, Qi Y et al. Macrophage migration inhibitory factor in hypothalamic paraventricular nucleus neurons decreases blood pressure in spontaneously hypertensive rats. FASEB J. 2008 22 : 3175 3185.
43. Allan SM, Rothwell NJ. Inflammation in central nervous system injury. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2003 358 : 1669 1677.
44. Breder CD, Tsujimoto M, Terano Y, Scott DW, Saper CB. Distribution and characterization of tumor necrosis factor-alpha-like immunoreactivity in the murine central nervous system. J. Comp. Neurol. 1993 337 : 543 567.
45. Vitkovic L, Bockaert J, Jacque C. 'Inflammatory' cytokines: Neuromodulators in normal brain? J. Neurochem. 2000 74 : 457 471.
46. Friedman WJ. Cytokines regulate expression of the type 1 interleukin-1 receptor in rat hippocampal neurons and glia. Exp. Neurol. 2001 168 : 23 31.
47. Rettori V, Belova N, Kamat A, Lyson K, Gimeno M, McCann SM. Blockade by interleukin-1-alpha of nitricoxidergic control of luteinizing hormone-releasing hormone release in vivo and in vitro. Neuroimmunomodulation 1994 1 : 86 91.
48. Yasuhara O, Matsuo A, Terai K et al. Expression of interleukin-1 receptor antagonist protein in post-mortem human brain tissues of Alzheimer's disease and control cases. Acta Neuropathol. 1997 93 : 414 420.
49. Fantuzzi G, Dinarello CA. Interleukin-18 and interleukin-1beta: Two cytokine substrates for ICE (caspase-1). J. ClImmunol. 1999 19 : 1 11.
50. Paton JF, Wang S, Polson JW, Kasparov S. Signalling across the blood brain barrier by angiotensin II. Novel implications for neurogenic hypertension. J. Mol. Med. 2008 86 : 705 710.
51. Landmesser U, Hornig B, Drexler H. Endothelial function: A critical determinant in atherosclerosis? Circulation 2004 109 (Suppl. II II-27 33.
52. Brunner H, Cockcroft JR, Deanfield J et al. Endothelial function and dysfunction. Part II. Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. J. Hypertens. 2005 23 : 233 246. (Pubitemid 40279622)
53. Feletou M, Vanhoutte PM. Endothelial dysfunction: A multifaceted disorder (The Wiggers Award Lecture). Am. J. Physiol. Heart Circ. Physiol. 2006 291 : H985 1002.
54. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: The role of oxidant stress. Circ. Res. 2000 87 : 840 844.
55. Harrison DG, Cai H, Landmesser U, Griendling KK. Interactions of angiotensin II with NAD(P)H oxidase, oxidant stress and cardiovascular disease. J. Renin Angiotensin Aldosterone Syst. 2003 4 : 51 61.